Compare Pharma Mar SA with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
21.26%
0%
21.26%
6 Months
27.45%
0%
27.45%
1 Year
22.42%
0%
22.42%
2 Years
161.71%
0%
161.71%
3 Years
174.41%
0%
174.41%
4 Years
41.62%
0%
41.62%
5 Years
13.54%
0%
13.54%
Pharma Mar SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.05%
EBIT Growth (5y)
-21.81%
EBIT to Interest (avg)
10.01
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.46
Sales to Capital Employed (avg)
0.93
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
18.83%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
68.10%
ROE (avg)
279.38%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
5.63
EV to EBIT
32.24
EV to EBITDA
26.89
EV to Capital Employed
9.77
EV to Sales
5.87
PEG Ratio
0.10
Dividend Yield
8.63%
ROCE (Latest)
30.31%
ROE (Latest)
29.79%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Mar 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.02%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
42.90
38.90
10.28%
Operating Profit (PBDIT) excl Other Income
1.80
-1.30
238.46%
Interest
0.00
0.80
-100.00%
Exceptional Items
0.00
-0.00
Consolidate Net Profit
1.50
-3.90
138.46%
Operating Profit Margin (Excl OI)
-7.10%
-83.30%
7.62%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 10.28% vs 2.37% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 138.46% vs -269.57% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
221.40
174.90
26.59%
Operating Profit (PBDIT) excl Other Income
48.30
9.30
419.35%
Interest
2.50
2.50
Exceptional Items
1.20
0.20
500.00%
Consolidate Net Profit
75.00
26.10
187.36%
Operating Profit Margin (Excl OI)
181.90%
14.70%
16.72%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 26.59% vs 10.56% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 187.36% vs 2,272.73% in Dec 2024
About Pharma Mar SA 
Pharma Mar SA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






